Challenge the current pediatric blood cancer landscape

Canadian researchers are invited to submit proposals to The Leukemia & Lymphoma Society of Canada’s Pediatric Blood Cancer Research Innovation Grant Competition. This grant is designed to challenge the current pediatric blood cancer landscape by providing funding for projects that will address unmet needs for pediatric blood cancers.

In the current era of targeted and immuno-oncology drugs being developed in adults, very few successful examples have been translated to childhood blood cancer treatment. Clear advances have occurred, but cure rates remain low for certain blood cancer types, along with considerable long-term effects from traditional therapies. For the benefit of children, a better understanding of tumor biology and further progress in drug development and treatment are needed.